Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study
- 18 October 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Urology
- Vol. 32 (4), 1049-1054
- https://doi.org/10.1007/s00345-013-1187-z
Abstract
Many men with "late-onset hypogonadism" (LOH) experience lower urinary tract symptoms (LUTS) that can be distressing and may decrease quality of life. LUTS often appear in men when testosterone levels begin to decline, which could be a significant association. We investigated whether testosterone replacement could alleviate LUTS in men with LOH. Two hundred and sixty-one hypogonadal patients (mean age 59.5 years) presenting with erectile dysfunction, having also been evaluated for LUTS, received a single testosterone undecanoate injection at day 1, at week 6 and quarterly thereafter. Parameters, including International Prostate Symptom Score (IPSS), post-voiding residual urine volume, transrectal ultrasound, prostate volume and prostate-specific antigen were measured at each treatment visit. Two hundred and fifty-nine patients were included in the full analysis set. These were subsequently divided into weight losers (L ≥ 5 % weight loss at last visit from baseline) and non-losers (NL). t test analyses were used to compare the IPSS means of these subgroups. The potentially confounding effect on IPSS of using the phosphodiesterase-5 inhibitor (PDE5i) vardenafil was also accounted for. Mean IPSS showed a significant decrease with time following initiation of testosterone treatment (p < 0.05). No significant differences were observed in either IPSS between L and NL groups or in mean IPSS between vardenafil users and non-users. Testosterone replacement is associated with improvements in LUTS which are not confounded by weight loss or PDE5i. The mechanisms of this association require further investigation.Keywords
This publication has 27 references indexed in Scilit:
- Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signalingAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Evaluation of the Association between Lower Urinary Tract Symptoms and Erectile Dysfunction, Considering its Multiple Risk FactorsThe Journal of Sexual Medicine, 2008
- Lower urinary-tract symptoms and testosterone in elderly menWorld Journal of Urology, 2008
- The triad of erectile dysfunction, hypogonadism and the metabolic syndromeInternational Journal of Clinical Practice, 2008
- An investigation of the relationship between sex‐steroid levels and urological symptoms: results from the Boston Area Community Health surveyBJU International, 2007
- Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and agingNature Clinical Practice Endocrinology & Metabolism, 2006
- Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS - implications for clinical practiceAndrologia, 2006
- Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’International Journal Of Impotence Research, 2000
- The effects of testosterone on the cavernous tissue and erectile functionWorld Journal of Urology, 1997
- Location and concentration of estrogen, progesterone, and androgen receptors in the bladder and urethra of the rabbitNeurourology and Urodynamics, 1995